As of Jul 21
| +0.005 / +1.20%|
The 1 analysts offering 12-month price forecasts for Inspyr Therapeutics Inc have a median target of 0.85, with a high estimate of 0.85 and a low estimate of 0.85. The median estimate represents a +102.38% increase from the last price of 0.42.
The current consensus among 1 polled investment analysts is to Buy stock in Inspyr Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.